118 related articles for article (PubMed ID: 8232345)
41. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
Schiffman MH; Bauer HM; Hoover RN; Glass AG; Cadell DM; Rush BB; Scott DR; Sherman ME; Kurman RJ; Wacholder S
J Natl Cancer Inst; 1993 Jun; 85(12):958-64. PubMed ID: 8388478
[TBL] [Abstract][Full Text] [Related]
42. Determination of integrated HPV58 sequences in cervical lesions.
Li H; Zhang R; Cai Y; Li Y; Cheng X; Zhu B; Yang Y; Xiang Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1234-7. PubMed ID: 22801029
[TBL] [Abstract][Full Text] [Related]
43. The physical state of human papillomavirus 16 DNA in cervical carcinoma and cervical intraepithelial neoplasia.
Fukushima M; Yamakawa Y; Shimano S; Hashimoto M; Sawada Y; Fujinaga K
Cancer; 1990 Nov; 66(10):2155-61. PubMed ID: 2171746
[TBL] [Abstract][Full Text] [Related]
44. [Differentiation of an integrated and episomal HPV-16 DNA using real-time PCR in cervical specimens of women diagnosed with intraepithelial lesions and invasive cervical cancer].
Szostek S; Zawilińska B; Klimek M; Wójcik K; Koprynia M; Kosz-Vnenchak M
Ginekol Pol; 2011 Jun; 82(6):441-5. PubMed ID: 21853934
[TBL] [Abstract][Full Text] [Related]
45. Use of the polymerase chain reaction to specifically amplify integrated HPV-16 DNA by virtue of its linkage to interspersed repetitive DNA.
Carmody MW; Jones M; Tarraza H; Vary CP
Mol Cell Probes; 1996 Apr; 10(2):107-16. PubMed ID: 8737394
[TBL] [Abstract][Full Text] [Related]
46. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
[TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women.
Chao A; Jao MS; Huang CC; Huang HJ; Cheng HH; Yang JE; Hsueh S; Chen TC; Qiu JT; Lin CT; Fu CJ; Chou HH; Lai CH
Int J Cancer; 2011 Feb; 128(3):653-9. PubMed ID: 20473874
[TBL] [Abstract][Full Text] [Related]
48. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
49. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features.
Butler D; Collins C; Mabruk M; Barry Walsh C; Leader MB; Kay EW
J Pathol; 2000 Dec; 192(4):502-10. PubMed ID: 11113868
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
51. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
[TBL] [Abstract][Full Text] [Related]
52. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ; Landers RJ; Silva I; Uhlmann V; Crowley M; Healy I; Luttich K
J Clin Pathol; 1998 Aug; 51(8):576-82. PubMed ID: 9828814
[TBL] [Abstract][Full Text] [Related]
53. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix.
Prokopakis P; Sourvinos G; Koumantaki Y; Koumantakis E; Spandidos DA
Oncol Rep; 2002; 9(1):129-33. PubMed ID: 11748470
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus integration: detection by in situ hybridization and potential clinical application.
Evans MF; Cooper K
J Pathol; 2004 Jan; 202(1):1-4. PubMed ID: 14694515
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
[TBL] [Abstract][Full Text] [Related]
56. Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix.
Kristiansen E; Jenkins A; Holm R
J Clin Pathol; 1994 Mar; 47(3):253-6. PubMed ID: 7677803
[TBL] [Abstract][Full Text] [Related]
57. Detection of human papillomavirus types in cervical lesions of patients from Taiwan by the polymerase chain reaction.
Wu CH; Lee MF; Chang MC; Ho SC
Sex Transm Dis; 1994; 21(6):309-14. PubMed ID: 7871443
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women.
Manavi M; Hudelist G; Fink-Retter A; Gschwantler-Kaulich D; Pischinger K; Czerwenka K
Int J Gynecol Cancer; 2008; 18(2):285-94. PubMed ID: 17587315
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of HPV in premalignant and malignant cervical lesions in Greenland and Denmark: PCR and in situ hybridization analysis on archival material.
Sebbelov AM; Svendsen C; Jensen H; Kjaer SK; Norrild B
Res Virol; 1994; 145(2):83-92. PubMed ID: 7520189
[TBL] [Abstract][Full Text] [Related]
60. [Role of herpes virus simplex and cytomegalovirus as cofactors of papillomavirus in dysplastic and cancerous lesions of the uterine cervix].
Baldauf JJ; Dreyfus M; Monlun E; Ritter J; Obert G
Chirurgie; 1992; 118(10):652-8. PubMed ID: 1345699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
